Health
COVID-19 vaccine | UK reserves 190 million doses from Valneva – Moneycontrol
Valneva said it expects to begin trials of the two-dose vaccine in December and if it is successful for it to become available in the second half of 2021.
Britain has secured access to up to 190 million doses of a potential coronavirus vaccine from French-Austrian biotech company Valneva, AFP reported.
The deal between the UK and Valnevaworth as much as 1.37 billion euros, the firm said on September 14.
It had already been disclosed in July that the British government had reserved 60 million doses of Valneva’s inactivated SARS-CoV-2 vaccine under development.
The firm said it expects to begin trials of the two-dose vaccine in December and if it…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General18 hours agoMigrants raise concerns over Australia’s English tests for visa applicants
-
Noosa News21 hours agoNew FLC President has regional lens – Proctor